NANJING, China Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive results in recent clinical study. D23 is ...
MedPage Today on MSN2d
RFK Jr. Points to Two Texas Doctors Treating Kids in Measles OutbreakIn a recent interview with Fox News, HHS Secretary Robert F. Kennedy, Jr. highlighted the work of two local physicians ...
Business Wire IndiaTriastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive results in recent clinical study. D23 is.
Triastek, a 3D pharmaceutical printing company, has reported positive results for its 3D printed drug, D23 (Budesonide Ileum-Targeted Tablets), designed to treat IgA nephropathy (IgAN). D23 is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results